Is Contineum Therapeutics, Inc. (CTNM) a Buy, Sell, or Hold?
NASDAQ : CTNM
Contineum Therapeutics, Inc.
$14.23 USD
$0.22 (1.57%)
- Volume
- 132.76K
- Average Volume
- 309.68K
- Market Capitalization
- $532.01M
- P/E Ratio
- -7.30
- Dividend Yield
- 0.00%
- Price Target
- $16.00
- Year High
- $16.91
- Year Low
- $4.67
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $38.00
Analyst Consensus Summary
Consensus Rating
Sell
3 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-11.1%
vs Current Price
Price Target
$16.00
Average TargetPrice Target Range
Lowest Target
$16.00
-11.1% DOWNSIDE
Average Target
$16.00
Median Estimate
Highest Target
$16.00
-11.1% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 3
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 2 | 1 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| RBC Capital | Brian Abrahams | $22 | $12.22 | 2025-11-21 08:42 AM | 80.0% |
| Robert W. Baird | Joel Beatty | $32 | $16.07 | 2024-10-21 12:54 PM | 99.1% |
| RBC Capital | Brian Abrahams | $30 | $16 | 2024-04-30 12:46 AM | 87.5% |
| Stifel Nicolaus | Paul Matteis | $29 | $16 | 2024-04-29 10:35 PM | 81.2% |